David Westenberg

Stock Analyst at Piper Sandler

(4.55)
# 275
Out of 5,042 analysts
179
Total ratings
57.28%
Success rate
21.19%
Average return

Stocks Rated by David Westenberg

Tempus AI
Oct 22, 2025
Maintains: Neutral
Price Target: $70$105
Current: $89.23
Upside: +17.67%
Guardant Health
Oct 22, 2025
Maintains: Overweight
Price Target: $60$90
Current: $72.15
Upside: +24.74%
Neogen
Oct 16, 2025
Reiterates: Neutral
Price Target: $5$6.5
Current: $6.19
Upside: +5.01%
Adaptive Biotechnologies
Oct 15, 2025
Maintains: Overweight
Price Target: $15$20
Current: $17.22
Upside: +16.14%
Exact Sciences
Oct 8, 2025
Maintains: Overweight
Price Target: $60$70
Current: $64.64
Upside: +8.29%
GeneDx Holdings
Sep 11, 2025
Maintains: Overweight
Price Target: $120$140
Current: $128.87
Upside: +8.64%
10x Genomics
Sep 11, 2025
Initiates: Neutral
Price Target: $15
Current: $13.77
Upside: +8.93%
Pacific Biosciences of California
Aug 11, 2025
Maintains: Neutral
Price Target: $1.25$1.5
Current: $2.02
Upside: -25.74%
Zoetis
Aug 11, 2025
Maintains: Overweight
Price Target: $210$215
Current: $145.94
Upside: +47.32%
IDEXX Laboratories
Aug 11, 2025
Maintains: Neutral
Price Target: $510$700
Current: $640.85
Upside: +9.23%
Maintains: Neutral
Price Target: $12$18
Current: $22.05
Upside: -18.37%
Maintains: Overweight
Price Target: $210$220
Current: $192.51
Upside: +14.28%
Maintains: Overweight
Price Target: $12$11
Current: $10.67
Upside: +3.09%
Maintains: Neutral
Price Target: $23$21
Current: $23.72
Upside: -11.47%
Maintains: Overweight
Price Target: $190$185
Current: $100.11
Upside: +84.80%
Maintains: Neutral
Price Target: $260$280
Current: $279.49
Upside: +0.18%
Maintains: Neutral
Price Target: $180$200
Current: $182.18
Upside: +9.78%
Maintains: Overweight
Price Target: $8.5$8
Current: $4.26
Upside: +87.79%
Upgrades: Buy
Price Target: n/a
Current: $30.51
Upside: -
Initiates: Neutral
Price Target: n/a
Current: $43.80
Upside: -